These findings underscore the multifaceted role of ROS in influencing the Ras-PI3K-Akt pathway in pancreatic cancer, primarily through the oxidation of critical cysteine residues within key proteins. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.